Philadelphia -- Smith Apisarnthanarax, MD, Assistant Professor, Perelman School of Medicine, and Associate Residency Program Director, Department of Radiation Oncology, was named Educator of the Year by the Association of Residents in Radiation Oncology (ARRO), in partnership with the American Society for Radiation Oncology (ASTRO).
Smith Apisarnthanarax, MD, Assistant Professor and Associate Residency Program Director, Department of Radiation Oncology, was named Educator of the Year by the Association of Residents in Radiation Oncology (ARRO), in partnership with the American Society for Radiation Oncology (ASTRO).
The award honors top teachers and mentors of radiation oncology residents. Residents from radiation oncology programs nationwide were offered the opportunity to nominate one faculty member from their program for this distinction. Residents are permitted to select clinical staff, physicists, biologists or other faculty. Among the 39 selected for the award this year include faculty from physics, biology and other areas.
"Proper education and training are not only essential to the foundation of medicine, they also provide the keys to advancing the field. The award recipients have demonstrated their ability to challenge residents to progress beyond their potential," said Eric Donnelly, MD, chairman of the ARRO Senior Executive Committee. "We are honored to recognize these individuals for their contributions to the future of radiation oncology."
Apisarnthanarax is involved in the training of 15 residents. "I feel extremely honored to receive this award for something that I truly enjoy doing - teaching and passing along knowledge that has been passed down to me to a really great group of residents," said Apisarnthanarax.
For more information on ASTRO or ARRO, please visit www.astro.org.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.